Cargando…
Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits
BACKGROUND: Preclinical rodent models for Parkinson’s disease (PD) based on viral human alpha-synuclein (h-αSyn) overexpression recapitulate some of the pathological hallmarks as it presents in humans, such as progressive cell loss and additional synucleinopathy in cortical and subcortical structure...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198765/ https://www.ncbi.nlm.nih.gov/pubmed/35213388 http://dx.doi.org/10.3233/JPD-212555 |
_version_ | 1784727699765329920 |
---|---|
author | Negrini, Matilde Tomasello, Giuseppe Davidsson, Marcus Fenyi, Alexis Adant, Cécile Hauser, Swantje Espa, Elena Gubinelli, Francesco Manfredsson, Fredric P. Melki, Ronald Heuer, Andreas |
author_facet | Negrini, Matilde Tomasello, Giuseppe Davidsson, Marcus Fenyi, Alexis Adant, Cécile Hauser, Swantje Espa, Elena Gubinelli, Francesco Manfredsson, Fredric P. Melki, Ronald Heuer, Andreas |
author_sort | Negrini, Matilde |
collection | PubMed |
description | BACKGROUND: Preclinical rodent models for Parkinson’s disease (PD) based on viral human alpha-synuclein (h-αSyn) overexpression recapitulate some of the pathological hallmarks as it presents in humans, such as progressive cell loss and additional synucleinopathy in cortical and subcortical structures. Recent studies have combined viral vector-based overexpression of human wild-type αSyn with the sequential or simultaneous inoculation of preformed fibrils (PFFs) derived from human αSyn. OBJECTIVE: The goal of the study was to investigate whether sequential or combined delivery of the AAV vector and the PFFs are equipotent in inducing stable neurodegeneration and behavioral deficits. METHODS: Here we compare between four experimental paradigms (PFFs only, AAV-h-αSyn only, AAV-h-αSyn with simultaneous PFFs, and AAV-h-αSyn with sequential PFFs) and their respective GFP control groups. RESULTS: We observed reduction of TH expression and loss of neurons in the midbrain in all AAV (h-αSyn or GFP) injected groups, with or without additional PFFs inoculation. The overexpression of either h-αSyn or GFP alone induced motor deficits and dysfunctional dopamine release/reuptake in electrochemical recordings in the ipsilateral striatum. However, we observed a substantial formation of insoluble h-αSyn aggregates and inflammatory response only when h-αSyn and PFFs were combined. Moreover, the presence of h-αSyn induced higher axonal pathology compared to control groups. CONCLUSION: Simultaneous AAV and PFFs injections are equipotent in the presented experimental setup in inducing histopathological and behavioral changes. This model provides new and interesting possibilities for characterizing PD pathology in preclinical models and means to assess future therapeutic interventions. |
format | Online Article Text |
id | pubmed-9198765 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | IOS Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91987652022-06-16 Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits Negrini, Matilde Tomasello, Giuseppe Davidsson, Marcus Fenyi, Alexis Adant, Cécile Hauser, Swantje Espa, Elena Gubinelli, Francesco Manfredsson, Fredric P. Melki, Ronald Heuer, Andreas J Parkinsons Dis Research Report BACKGROUND: Preclinical rodent models for Parkinson’s disease (PD) based on viral human alpha-synuclein (h-αSyn) overexpression recapitulate some of the pathological hallmarks as it presents in humans, such as progressive cell loss and additional synucleinopathy in cortical and subcortical structures. Recent studies have combined viral vector-based overexpression of human wild-type αSyn with the sequential or simultaneous inoculation of preformed fibrils (PFFs) derived from human αSyn. OBJECTIVE: The goal of the study was to investigate whether sequential or combined delivery of the AAV vector and the PFFs are equipotent in inducing stable neurodegeneration and behavioral deficits. METHODS: Here we compare between four experimental paradigms (PFFs only, AAV-h-αSyn only, AAV-h-αSyn with simultaneous PFFs, and AAV-h-αSyn with sequential PFFs) and their respective GFP control groups. RESULTS: We observed reduction of TH expression and loss of neurons in the midbrain in all AAV (h-αSyn or GFP) injected groups, with or without additional PFFs inoculation. The overexpression of either h-αSyn or GFP alone induced motor deficits and dysfunctional dopamine release/reuptake in electrochemical recordings in the ipsilateral striatum. However, we observed a substantial formation of insoluble h-αSyn aggregates and inflammatory response only when h-αSyn and PFFs were combined. Moreover, the presence of h-αSyn induced higher axonal pathology compared to control groups. CONCLUSION: Simultaneous AAV and PFFs injections are equipotent in the presented experimental setup in inducing histopathological and behavioral changes. This model provides new and interesting possibilities for characterizing PD pathology in preclinical models and means to assess future therapeutic interventions. IOS Press 2022-05-24 /pmc/articles/PMC9198765/ /pubmed/35213388 http://dx.doi.org/10.3233/JPD-212555 Text en © 2022 – The authors. Published by IOS Press https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Report Negrini, Matilde Tomasello, Giuseppe Davidsson, Marcus Fenyi, Alexis Adant, Cécile Hauser, Swantje Espa, Elena Gubinelli, Francesco Manfredsson, Fredric P. Melki, Ronald Heuer, Andreas Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits |
title | Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits |
title_full | Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits |
title_fullStr | Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits |
title_full_unstemmed | Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits |
title_short | Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits |
title_sort | sequential or simultaneous injection of preformed fibrils and aav overexpression of alpha-synuclein are equipotent in producing relevant pathology and behavioral deficits |
topic | Research Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198765/ https://www.ncbi.nlm.nih.gov/pubmed/35213388 http://dx.doi.org/10.3233/JPD-212555 |
work_keys_str_mv | AT negrinimatilde sequentialorsimultaneousinjectionofpreformedfibrilsandaavoverexpressionofalphasynucleinareequipotentinproducingrelevantpathologyandbehavioraldeficits AT tomasellogiuseppe sequentialorsimultaneousinjectionofpreformedfibrilsandaavoverexpressionofalphasynucleinareequipotentinproducingrelevantpathologyandbehavioraldeficits AT davidssonmarcus sequentialorsimultaneousinjectionofpreformedfibrilsandaavoverexpressionofalphasynucleinareequipotentinproducingrelevantpathologyandbehavioraldeficits AT fenyialexis sequentialorsimultaneousinjectionofpreformedfibrilsandaavoverexpressionofalphasynucleinareequipotentinproducingrelevantpathologyandbehavioraldeficits AT adantcecile sequentialorsimultaneousinjectionofpreformedfibrilsandaavoverexpressionofalphasynucleinareequipotentinproducingrelevantpathologyandbehavioraldeficits AT hauserswantje sequentialorsimultaneousinjectionofpreformedfibrilsandaavoverexpressionofalphasynucleinareequipotentinproducingrelevantpathologyandbehavioraldeficits AT espaelena sequentialorsimultaneousinjectionofpreformedfibrilsandaavoverexpressionofalphasynucleinareequipotentinproducingrelevantpathologyandbehavioraldeficits AT gubinellifrancesco sequentialorsimultaneousinjectionofpreformedfibrilsandaavoverexpressionofalphasynucleinareequipotentinproducingrelevantpathologyandbehavioraldeficits AT manfredssonfredricp sequentialorsimultaneousinjectionofpreformedfibrilsandaavoverexpressionofalphasynucleinareequipotentinproducingrelevantpathologyandbehavioraldeficits AT melkironald sequentialorsimultaneousinjectionofpreformedfibrilsandaavoverexpressionofalphasynucleinareequipotentinproducingrelevantpathologyandbehavioraldeficits AT heuerandreas sequentialorsimultaneousinjectionofpreformedfibrilsandaavoverexpressionofalphasynucleinareequipotentinproducingrelevantpathologyandbehavioraldeficits |